Marta Casal Moura, Marc Patricio Liebana, Ladan Zand, Dalia Zubidat, Maria J Vargas-Brochero, Daniela Valencia, Miriam Machado, Sana Abouzahir, Ulrich Specks, Sanjeev Sethi, Fernando C Fervenza, Maria José Soler
{"title":"ANCA血管炎并发严重肾脏疾病的性别特异性临床表现和结局","authors":"Marta Casal Moura, Marc Patricio Liebana, Ladan Zand, Dalia Zubidat, Maria J Vargas-Brochero, Daniela Valencia, Miriam Machado, Sana Abouzahir, Ulrich Specks, Sanjeev Sethi, Fernando C Fervenza, Maria José Soler","doi":"10.1093/ndt/gfaf120","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The impact of sex in the clinical presentation and outcomes of patients with anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) with glomerulonephritis (AAV-GN) has not been studied, particularly in patients with severe kidney involvement at presentation (eGFR < 15 mL/min/1.73m2).</p><p><strong>Methods: </strong>A retrospective cohort study on MPO- or PR3-ANCA positive patients with AAV (MPA or GPA) and eGFR<15 ml/min/1.73m2 or end-stage kidney disease (ESKD) at presentation. Clinical presentation and renal outcomes were analyzed according with sex.</p><p><strong>Results: </strong>We analyzed 166 patients with biopsy proven active AAV-GN and eGFR < 15 mL/min/1.73m2 at the time of diagnosis: 78 (47%) were females and 88 (53%) were males. Hypertension was more frequently present in males (85.2% vs.70.5%, P = 0.022). Median serum creatinine (SCr) was higher in males when compared with females (5.2 [IQR 4.2-7.4] vs. 3.6 [IQR 2.8-5.1]mg/dL, P < 0.001). There were no statistically significant differences in the median percentage of crescents. However, the rate of dialysis initiation or progression to ESKD in the first 12 months was not different between males (15, 62.5%) versus females (29, 61.7%) at 12 months. By multivariable logistic regression, factors related with dialysis initiation within the first 4 weeks in our cohort were SCr, alveolar hemorrhage, and PR3-ANCA adjusted for sex.</p><p><strong>Conclusion: </strong>In our cohort, male patients presented with higher SCr, and dialysis was started within the first 4 weeks more frequently (53.4% vs. 30.7%). There were no differences in outcomes of kidney recovery, overall dialysis rates, and progression to ESKD within 12 months in patients with AAV-GN and eGFR < 15 mL/min/1.73m2 between groups.</p>","PeriodicalId":520717,"journal":{"name":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","volume":" ","pages":""},"PeriodicalIF":5.6000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sex-specific clinical presentations and outcomes in ANCA vasculitis presenting with severe kidney disease.\",\"authors\":\"Marta Casal Moura, Marc Patricio Liebana, Ladan Zand, Dalia Zubidat, Maria J Vargas-Brochero, Daniela Valencia, Miriam Machado, Sana Abouzahir, Ulrich Specks, Sanjeev Sethi, Fernando C Fervenza, Maria José Soler\",\"doi\":\"10.1093/ndt/gfaf120\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The impact of sex in the clinical presentation and outcomes of patients with anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) with glomerulonephritis (AAV-GN) has not been studied, particularly in patients with severe kidney involvement at presentation (eGFR < 15 mL/min/1.73m2).</p><p><strong>Methods: </strong>A retrospective cohort study on MPO- or PR3-ANCA positive patients with AAV (MPA or GPA) and eGFR<15 ml/min/1.73m2 or end-stage kidney disease (ESKD) at presentation. Clinical presentation and renal outcomes were analyzed according with sex.</p><p><strong>Results: </strong>We analyzed 166 patients with biopsy proven active AAV-GN and eGFR < 15 mL/min/1.73m2 at the time of diagnosis: 78 (47%) were females and 88 (53%) were males. Hypertension was more frequently present in males (85.2% vs.70.5%, P = 0.022). Median serum creatinine (SCr) was higher in males when compared with females (5.2 [IQR 4.2-7.4] vs. 3.6 [IQR 2.8-5.1]mg/dL, P < 0.001). There were no statistically significant differences in the median percentage of crescents. However, the rate of dialysis initiation or progression to ESKD in the first 12 months was not different between males (15, 62.5%) versus females (29, 61.7%) at 12 months. By multivariable logistic regression, factors related with dialysis initiation within the first 4 weeks in our cohort were SCr, alveolar hemorrhage, and PR3-ANCA adjusted for sex.</p><p><strong>Conclusion: </strong>In our cohort, male patients presented with higher SCr, and dialysis was started within the first 4 weeks more frequently (53.4% vs. 30.7%). There were no differences in outcomes of kidney recovery, overall dialysis rates, and progression to ESKD within 12 months in patients with AAV-GN and eGFR < 15 mL/min/1.73m2 between groups.</p>\",\"PeriodicalId\":520717,\"journal\":{\"name\":\"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ndt/gfaf120\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ndt/gfaf120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sex-specific clinical presentations and outcomes in ANCA vasculitis presenting with severe kidney disease.
Background: The impact of sex in the clinical presentation and outcomes of patients with anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) with glomerulonephritis (AAV-GN) has not been studied, particularly in patients with severe kidney involvement at presentation (eGFR < 15 mL/min/1.73m2).
Methods: A retrospective cohort study on MPO- or PR3-ANCA positive patients with AAV (MPA or GPA) and eGFR<15 ml/min/1.73m2 or end-stage kidney disease (ESKD) at presentation. Clinical presentation and renal outcomes were analyzed according with sex.
Results: We analyzed 166 patients with biopsy proven active AAV-GN and eGFR < 15 mL/min/1.73m2 at the time of diagnosis: 78 (47%) were females and 88 (53%) were males. Hypertension was more frequently present in males (85.2% vs.70.5%, P = 0.022). Median serum creatinine (SCr) was higher in males when compared with females (5.2 [IQR 4.2-7.4] vs. 3.6 [IQR 2.8-5.1]mg/dL, P < 0.001). There were no statistically significant differences in the median percentage of crescents. However, the rate of dialysis initiation or progression to ESKD in the first 12 months was not different between males (15, 62.5%) versus females (29, 61.7%) at 12 months. By multivariable logistic regression, factors related with dialysis initiation within the first 4 weeks in our cohort were SCr, alveolar hemorrhage, and PR3-ANCA adjusted for sex.
Conclusion: In our cohort, male patients presented with higher SCr, and dialysis was started within the first 4 weeks more frequently (53.4% vs. 30.7%). There were no differences in outcomes of kidney recovery, overall dialysis rates, and progression to ESKD within 12 months in patients with AAV-GN and eGFR < 15 mL/min/1.73m2 between groups.